📰 Merck Sharp News
Page 4 - Merck Sharp News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Merck Sharp. Real-time updates on events, politics, business and more.
April 23, 2024
Two of six patients receiving NOX-A12 in combination with bevacizumab and radiotherapy exceeded 24-month survival since the start of therapy This survival compares favorably to the 5% survival...
April 23, 2024
A 5-year randomised, placebo-controlled trial of pembrolizumab found a 38% reduction in death vs placebo.
April 23, 2024
Dublin, April 23, 2024 (GLOBE NEWSWIRE) -- The
April 21, 2024
In this article, we discuss the 11 hot growth stocks to buy now.
April 21, 2024
In this article, we discuss the 11 hot growth stocks to buy now. If you want to read about some more growth stocks that are active in the market, go directly to the 5 Hot Growth Stocks To Buy Right Now. As 2024 moves forward, the outlook for both the stock and bond markets undergoes […]
April 18, 2024
The Pharmaceutical Journal from the Royal Pharmaceutical Society
April 12, 2024
From that point in time, BigPharma was joined in tandem by a majority of Governments around the world, together with en masse reporting by the global media,
April 12, 2024
Using nearly 1.5 million health records from >350,000 older adults with diabetes in Hong Kong, Elaine Chow and colleagues investigate a novel machine learning model to predict risk of severe hypoglycaemia.
April 12, 2024
EQS-News: Formycon AG / Key word: Preliminary Results/Forecast Convincing overall performance - Formycon reports preliminary results for the financial year 2023 and exceeds...
April 12, 2024
EQS-News: Formycon AG / Key word(s): Preliminary Results/ForecastConvincing overall performance - Formycon reports preliminary results for the financial year 2023 and exceeds forecast 12.04.2024 / 22:15 CET/CESTThe issuer is solely responsible for the content of this announcement.Press release // 12 April 2024 ...